In SAMP8 accelerated-aging mice versus senescence-resistant SAMR1 controls, gut microbial diversity diverged independently of age, with nine bacterial genera correlating with immune cell frequencies. The genus Intestinimonas remained persistently elevated in aged SAMP8 mice and displayed a striking discordant relationship with the CD4⁺/CD8⁺ ratio — negative in the brain, positive in the spleen. Brain tissue in SAMP8 mice showed elevated CD4⁺/CD8⁺ ratios and higher pro-inflammatory cytokine-producing CD4⁺ T cells, while splenic T-cell activation (effector/naïve ratios) increased only in aged SAMP8. Critically, CD8⁺ T-cell variation correlated with microbiota composition more strongly than strain, age, or sex combined.
This is a mechanistically rich finding that advances the gut-brain-immunity axis beyond epidemiological association. The tissue-specific immune divergence — pro-inflammatory skewing in brain versus suppressed splenic CD4⁺/CD8⁺ — suggests the microbiome doesn't simply modulate systemic immunity but shapes compartment-specific T-cell landscapes relevant to neuroinflammation. Intestinimonas, a butyrate-producing anaerobe, makes a counterintuitive villain here; its elevated presence correlating with unfavorable brain immune profiles warrants targeted mechanistic follow-up. Limitations are significant: this is a mouse model with artificial senescence acceleration, and SAMP8 mice carry genetic confounders beyond microbiota. Causal directionality remains unproven — does dysbiosis drive neuro-immune aging, or vice versa? For human longevity research, the finding that CD8⁺ T cells track microbiome composition so tightly is genuinely novel and suggests microbial modulation as a potential lever against brain immunosenescence.
